MERLIN

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark MERLIN was filed as Word mark on 10/26/2020 at the World Intellectual Property Organization.

Trademark Details Last update: September 6, 2022

Trademark form Word mark
File reference 1572753
Countries European Community United Kingdom Japan United States of America (USA)
Base trademark BX No. 1421678, July 22, 2020
Application date October 26, 2020
Expiration date October 26, 2030

Trademark owner

Lichtenauerlaan 40
3062 ME Rotterdam
NL

Trademark representatives

Carnegieplein 5 2517 KJ Den Haag NL

goods and services

05 Molecular diagnostic test reagents; molecular diagnostic test reagents of body substances, such as bone marrow samples, blood samples, and on human or animal tissue; molecular diagnostic test reagents for cancer; molecular diagnostic test reagents, inter alia on the basis of microarray technology (next generation) sequencing technology; reagents for use in medical genetic testing; reagents for use in medical genetic testing for the measurement of the gene expression profile; reagents for use in medical genetic testing for the measurement of gene aberrations and mutations; clinical diagnostic test reagents for determination of genetic sub-type of a patient; prognostic test reagents; predictive test reagents, in search of the effectiveness of a medical treatment and/or to select the medical treatment; diagnostic test reagents and preparations for medical or veterinary purposes; chemical preparations, for medical purposes, for the testing of blood and human or animal tissue, including cancer cells; medical diagnostic test strips; diagnostic testing materials for medical use; preparations for detecting mutation in genes for medical purposes
42 Research and development of new products for others; biochemical research and development; pharmaceutical research and development; research and development in the field of diagnostic preparations; biological research, clinical research and medical research; scientific research for the benefit of the development of molecular diagnostic tests; analysis and evaluation of results from quality control tests; molecular diagnostic analysis; investigation and analysis of body substances and molecular diagnostic test scores for the purpose of the development of new biomarkers; development and diagnostic testing of treatment methods; development and testing services for the certification of quality or standards of (molecular) diagnostic tests; computer aided diagnostic testing services; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; research in the field of gene therapy; research and diagnostic testing services in the field of skin cancer
44 Medical analysis services; medical analysis services using test scores and data for medical or veterinary purposes for others; medical and veterinary information services provided via the internet; medical testing for diagnostic or treatment purposes; medical diagnostic services; medical analysis services for cancer diagnosis and prognosis; medical services for the treatment of skin cancer; medical analysis services for the diagnosis of cancer

Trademark history

Date Document number Area Entry
September 1, 2022 2022/36 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
July 19, 2022 2022/29 Gaz Deletion
May 1, 2022 2022/18 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
December 2, 2021 2021/48 Gaz JP Rejection
July 24, 2021 2021/30 Gaz GB Rejection
June 16, 2021 2021/24 Gaz EM Rejection
April 6, 2021 2021/14 Gaz US Rejection
February 19, 2021 2021/8 Gaz AU Rejection
October 26, 2020 2021/2 Gaz BX Registration

ID: 141572753